USAID Grants $10M To DNDi For NTD Drug R&D

Drugs for Neglected Diseases initiative: DNDi Receives US$ 10 Million from USAID to Develop New Drugs for Neglected Filaria Patients
“The Drugs for Neglected Diseases initiative (DNDi) has been awarded US$ 10 million by the United States Agency for International Development (USAID) to develop new treatments for onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis) — the first-ever USAID grant for neglected tropical disease research and development (R&D)…” (12/16).